Search

everythinglearnresearchcommunity

for

Search:↓

Mesotherapy is not significantly better than minoxidil for treating male hair loss.

The document concludes that it's important to recognize and treat hair loss in women of color, considering their unique hair characteristics and psychological impact.

New regenerative medicine-based therapies for hair loss look promising but need more clinical validation.

Minoxidil, originally a blood pressure medication, is effective in treating hair loss in men and women, with different strengths recommended for each.

The research found no clear link between the severity of male baldness and the scalp examination findings in Indonesian men.

Higher cell number PRP improves hair density and diameter more than lower cell number PRP.

Using more than 5% minoxidil can help hair growth more, but results vary and side effects may increase.

QR678 Neo® improved seborrheic dermatitis symptoms in a small group of patients.

Androgenetic alopecia, or hair loss, is caused by a mix of genetics, hormones, and environment, where testosterone affects hair growth and causes hair to become smaller and grow for a shorter time.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

A vitamin and mineral supplement significantly reduced hair shedding in Brazilian women with telogen effluvium.

Most patients with chronic hair shedding did not progress to permanent hair loss, and one showed improvement with treatment.

COVID-19 infection may cause significant hair loss, but full hair recovery is likely without special treatment.

The type 3 IP3 receptor is important for controlling hair loss and growth.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Acute telogen effluvium can be resolved by addressing causes, but chronic telogen effluvium is harder to treat.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

Manage hair shedding by identifying triggers, possibly using supplements or medications, and tracking with a health calendar.

Woman's hair loss diagnosis changed from CTE to AA; multiple biopsies important for accurate diagnosis.

Chronic telogen effluvium may not be a unique condition and could be confused with other types of hair loss.

Telogen effluvium is a reversible hair loss condition that requires a detailed diagnosis and often resolves on its own.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

A liquid protein diet caused hair loss in a young woman.

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

Lactoferrin levels are lower in people with chronic hair shedding, suggesting supplements could help treat it.

Low iron and L-lysine levels can cause hair loss in women, and increasing these nutrients can reduce hair shedding.

Pregnancy can cause normal skin changes that usually go away after childbirth and don't need treatment.

The model showed that randomness accurately describes individual hair growth cycles and that synchronization can cause large fluctuations not seen in humans.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

High levels of prolactin in the blood can be linked to widespread hair loss.